» Authors » R M Winslow

R M Winslow

Explore the profile of R M Winslow including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 110
Citations 986
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mostl C, Amerstorfer T, Palmerio E, Isavnin A, Farrugia C, Lowder C, et al.
Space Weather . 2018 May; 16(3):216-229. PMID: 29780287
Forecasting the geomagnetic effects of solar storms, known as coronal mass ejections (CMEs), is currently severely limited by our inability to predict the magnetic field configuration in the CME magnetic...
2.
Lugaz N, Farrugia C, Winslow R, Al-Haddad N, Kilpua E, Riley P
J Geophys Res Space Phys . 2018 Apr; 121(11):10861-10879. PMID: 29629250
We identify all fast-mode forward shocks, whose sheath regions resulted in a moderate (56 cases) or intense (38 cases) geomagnetic storm during 18.5 years from January 1997 to June 2015....
3.
Mostl C, Isavnin A, Boakes P, Kilpua E, Davies J, Harrison R, et al.
Space Weather . 2017 Oct; 15(7):955-970. PMID: 28983209
We present an advance toward accurately predicting the arrivals of coronal mass ejections (CMEs) at the terrestrial planets, including Earth. For the first time, we are able to assess a...
4.
Vandegriff K, Young M, Lohman J, Bellelli A, Samaja M, Malavalli A, et al.
Br J Pharmacol . 2008 Jun; 154(8):1649-61. PMID: 18536756
Background And Purpose: MP4 (Hemospan) is a Hb-based oxygen therapeutic agent, based on polyethylene-glycol (PEG) conjugation to Hb, undergoing clinical trials as an oxygen carrier. This study describes the functional...
5.
Olofsson C, Nygards E, Ponzer S, Fagrell B, Przybelski R, Keipert P, et al.
Transfus Med . 2008 Feb; 18(1):28-39. PMID: 18279190
The objective of this study was to further explore the safety of Hemospan (Sangart Inc., San Diego, CA, USA), an oxygen-carrying plasma expander. The aim of this study was to...
6.
Winslow R
Vox Sang . 2006 Aug; 91(2):102-10. PMID: 16907870
An alternative to blood transfusion, based on oxygen-carrying solutions, has been sought for over a century. The present 'first-generation' haemoglobin-products were based on observations that crosslinking with, for example, glutaraldehyde,...
7.
Winslow R
IDrugs . 2005 Sep; 2(4):340-54. PMID: 16158353
Blood substitutes are oxygen-carrying plasma expanders intended to be used instead of blood. Their development is a long-standing quest and seen as being one of the several most important prizes...
8.
Winslow R
J Intern Med . 2003 Apr; 253(5):508-17. PMID: 12702028
For many reasons, haemoglobin, modified to prolong its circulation time, seems to be the optimal choice for a cell-free O2 carrier (blood substitute) because of its capacity to reversibly bind...
9.
Manjula B, Tsai A, Upadhya R, Perumalsamy K, Smith P, Malavalli A, et al.
Bioconjug Chem . 2003 Mar; 14(2):464-72. PMID: 12643758
Increasing the molecular size of acellular hemoglobin (Hb) has been proposed as an approach to reduce its undesirable vasoactive properties. The finding that bovine Hb surface decorated with about 10...
10.
McCarthy M, Vandegriff K, Winslow R
Biophys Chem . 2001 Aug; 92(1-2):103-17. PMID: 11527583
We compared rates of oxygen transport in an in vitro capillary system using red blood cells (RBCs) and cell-free hemoglobins. The axial PO(2) drop down the capillary was calculated using...